Labcorp Growth Push Meets Cost and Reimbursement Risks
Specialty testing, acquisitions and margin gains support expansion, while higher costs and reimbursement changes remain risks.
Makkler Newsroom · Sep 29, 04:07 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $392.93 (+6.1%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO